SciTech developing cancer drug in Detroit’s TechTown, plans to hire 10 people
SciTech doesn’t just see the light at the end of the tunnel for its latest cancer-fighting drug, it sees a drug with a bright future that can create lots of jobs in Detroit.
SciTech is working on a drug that promises to be a versatile weapon in the fight against cancer …and fight for job-creating businesses in Detroit.
Excerpt:
SciTech Development sees a bright future for the drug it is working on as both a cancer fighter and an economic driver.
The Wayne State University and Karmanos Cancer Institute spin-off is working on making the drug fenretinide reach its full potential as a cancer fight agent. The seven-person firm has been working on this at TechTown since 2001 and sees it realizing its large upside within the next three years.
Read the rest of the story here.